Merck: Navigating Patent Cliff and Growth Prospects
Merck faces the challenge of expiring patents while pushing a robust pipeline and disciplined capital moves. This gui...
Using index funds with active funds works best in markets with clear diversification needs and where costs and risk management matter most.
21,614 articlesMerck faces the challenge of expiring patents while pushing a robust pipeline and disciplined capital moves. This gui...
A landmark $1.5 billion bet on counter-drone tech sets Motorola Solutions up for deeper public-safety leadership. Her...
Insider moves can shape sentiment, but they aren’t a stand-alone signal. This deep dive explains what c3.ai's sold 17...
Red Cat Holdings faced a sharp price move after news about a government contract came with unclear value. This articl...
Small-cap biotech Aethlon Medical faces a pivotal year in 2026. This guide breaks down what to watch in aethlon (aemd...
Celebrities often share headlines about growing families, but behind those moments lie real financial planning. This ...
The AI boom is reshaping the tech stock landscape, putting Nvidia and Micron in the spotlight. This guide teases out ...
Small modular reactor stocks trading under $10 can look tempting, but prices don’t always reflect real value. This gu...
Nvidia publicly praising Marvell Technology sparked a sharp price move and fresh debate about AI-driven growth. This ...
A seasoned Mission Produce director just bought a substantial block of shares, signaling confidence in AVO. This arti...
On June 22, the tape showed mixed signals: tech weakness dragged major indices lower, while staple names and other de...
A sudden government shutdown of an AI model can upend markets in days. This guide breaks down what it means for inves...